ABVX — Abivax SA Share News
0.000.00%
Last trade - 00:00France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data
Brief: Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Abivax shares rise after expanded share sales amid strong investor demand
Brief: Abivax Nets $920 Mln In Gross Proceeds From ADS Offering
Abivax nears $11 billion valuation after fundraising eases M&A pressure
Abivax extends gains after upsized $800 mln share sale
Brief: Abivax Announces Temporary Trading Halt Of Its Ordinary Shares On Euronext Paris
Brief: Eqs-News Abivax Announces Launch Of Public Offering Of American Depositary Shares
Abivax dips after launching $600 mln share offering
Live Markets: STOXX near peaks as AI trade rolls on
Abivax jumps after data address obefazimod safety concerns
Live Markets: Before the bell: Europe eyes best quarter since 2022
Abivax inflammatory bowel drug shows benefit in relapsed and non-responding patients (updated)
Abivax inflammatory bowel drug shows benefit in relapsed and non-responding patients
NASDAQ RESUMED AT 05:05 PM